Clinical Trials
3 trialsNCT07193186 2026-02-27
Anlotinib and Benmelstobart in DTC
Fudan University
Phase 2 Not yet recruiting
NCT05659186 2022-12-21
PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer
West China Hospital
Phase 2 Unknown
NCT04309136 2021-04-01
Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer
Fudan University
Phase 2 Unknown